NCT00163111View on ClinicalTrials.gov

A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.

PHASE3CompletedINTERVENTIONAL
Enrollment

412

Participants

Timeline

Start Date

September 30, 1998

Study Completion Date

May 31, 2003

Conditions
Candidiasis
Interventions
DRUG

VFEND® I.V., Oral

DRUG

Conventional amphotericin B

DRUG

Diflucan IV, oral

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00163111 - A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood. | Biotech Hunter | Biotech Hunter